ImportRefusal LogoImportRefusal

Colgate-Palmolive China

⚠️ High Risk

FEI: 3004124961 • Guangzhou, Guangdong • CHINA

FEI

FEI Number

3004124961

📍

Location

Guangzhou, Guangdong

🇨🇳

Country

CHINA
🏢

Address

338 Qingnian Road Xin Gang Huangpu, Getdd, , Guangzhou, Guangdong, China

High Risk

FDA Import Risk Assessment

54.9
LowModerateHighCritical

This firm has a significant history of FDA import refusals with notable violations.

Statistics

16
Total Refusals
8
Unique Violations
10/31/2025
Latest Refusal
6/12/2006
Earliest Refusal

Score Breakdown

Violation Severity
52.9×40%
Refusal Volume
45.6×30%
Recency
96.2×20%
Frequency
8.3×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

11815×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

4728×

NO ENGLISH

Required label or labeling appears to not be in English in violation of 21 C.F.R. 201.15(c)(1).

168×

DIRECTIONS

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it is a device whose label appears to not bear adequate directions for use.

32804×

FRNMFGREG

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.

752×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

22802×

DIRSEXMPT

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a drug within the meaning of Section 201(g) and it lacks adequate directions for use.

3361×

INCONSPICU

Information required by the Act to be on the label or labeling does not appear to be conspicuous enough as to render it likely to be read and understood by the ordinary individual under customary conditions of purchase and use.

3301×

UNSAFE COL

The article appears to be a color additive for the purposes of coloring only in or on drugs or devices, and is unsafe within the meaning of Section 721(a).

Refusal History

DateProductViolationsDivision
10/31/2025
63RCY06STANNOUS FLUORIDE (DENTAL CARIES PROPHYLACTIC)
118NOT LISTED
3280FRNMFGREG
Division of Northeast Imports (DNEI)
9/12/2025
63RAY04SODIUM FLUORIDE (DENTAL CARIES PROPHYLACTIC)
118NOT LISTED
3280FRNMFGREG
Division of Northeast Imports (DNEI)
4/3/2025
53IG01DENTIFRICES (AEROSOL, LIQUID, TOOTHPASTES, TOOTHPOWDERS), WITHOUT FLUORIDE (ORAL HYGIENE PRODUCTS)
118NOT LISTED
2280DIRSEXMPT
3280FRNMFGREG
336INCONSPICU
75UNAPPROVED
Division of Northeast Imports (DNEI)
4/3/2025
63RBG06STANNOUS FLUORIDE (DENTAL CARIES PROPHYLACTIC)
118NOT LISTED
2280DIRSEXMPT
3280FRNMFGREG
Division of Northeast Imports (DNEI)
8/27/2024
63RBY06STANNOUS FLUORIDE (DENTAL CARIES PROPHYLACTIC)
330UNSAFE COL
75UNAPPROVED
Division of Northeast Imports (DNEI)
7/10/2012
63RAY05SODIUM MONOFLUOROPHOSPHATE (DENTAL CARIES PROPHYLACTIC)
118NOT LISTED
16DIRECTIONS
472NO ENGLISH
New York District Office (NYK-DO)
7/10/2012
63RAY05SODIUM MONOFLUOROPHOSPHATE (DENTAL CARIES PROPHYLACTIC)
118NOT LISTED
16DIRECTIONS
472NO ENGLISH
New York District Office (NYK-DO)
7/10/2012
63RAY05SODIUM MONOFLUOROPHOSPHATE (DENTAL CARIES PROPHYLACTIC)
118NOT LISTED
16DIRECTIONS
472NO ENGLISH
New York District Office (NYK-DO)
7/10/2012
63RAY05SODIUM MONOFLUOROPHOSPHATE (DENTAL CARIES PROPHYLACTIC)
118NOT LISTED
16DIRECTIONS
472NO ENGLISH
New York District Office (NYK-DO)
7/10/2012
63RAY05SODIUM MONOFLUOROPHOSPHATE (DENTAL CARIES PROPHYLACTIC)
118NOT LISTED
16DIRECTIONS
472NO ENGLISH
New York District Office (NYK-DO)
7/10/2012
63RAY05SODIUM MONOFLUOROPHOSPHATE (DENTAL CARIES PROPHYLACTIC)
118NOT LISTED
16DIRECTIONS
472NO ENGLISH
New York District Office (NYK-DO)
7/10/2012
63RAY05SODIUM MONOFLUOROPHOSPHATE (DENTAL CARIES PROPHYLACTIC)
118NOT LISTED
16DIRECTIONS
472NO ENGLISH
New York District Office (NYK-DO)
7/10/2012
63RAY05SODIUM MONOFLUOROPHOSPHATE (DENTAL CARIES PROPHYLACTIC)
118NOT LISTED
16DIRECTIONS
472NO ENGLISH
New York District Office (NYK-DO)
8/6/2007
63RBY06STANNOUS FLUORIDE (DENTAL CARIES PROPHYLACTIC)
118NOT LISTED
Chicago District Office (CHI-DO)
8/6/2007
63RBY06STANNOUS FLUORIDE (DENTAL CARIES PROPHYLACTIC)
118NOT LISTED
Chicago District Office (CHI-DO)
6/12/2006
63RBJ04SODIUM FLUORIDE (DENTAL CARIES PROPHYLACTIC)
118NOT LISTED
New York District Office (NYK-DO)

Frequently Asked Questions

What is Colgate-Palmolive China's FDA import refusal history?

Colgate-Palmolive China (FEI: 3004124961) has 16 FDA import refusal record(s) in our database, spanning from 6/12/2006 to 10/31/2025.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Colgate-Palmolive China's FEI number is 3004124961.

What types of violations has Colgate-Palmolive China received?

Colgate-Palmolive China has been cited for 8 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Colgate-Palmolive China come from?

All FDA import refusal data for Colgate-Palmolive China is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.